. Circle 144 on Reader Service Card Bio Med Sciences introd uces two new sizes of its Si lon -T SR® T e mp o ra r y Sk in Rep lace me nt product. Silon-TSR has beco me a ·stan-dard treatment for seco nd-deg ree burns and laser resurfacing wo unds since first introduced in 1992. Recent clinical experience has broad ene d the product' s range of applications to includ e other types of wounds. Silon-TSR is now increasingly recogni zed as a safe and effec tive alterna tive for skin tears and other types of fragile wounds, including radi ation necrosis and ep ider malysis bullosa.
Th e two new sizes of Silon-TSR -2.5 x 2.5 inches (6 x 6 em) and 3 x 4.7 inches (7.5 x 12 em) -were deve loped to impr ove cost effec tiveness and ease of use for the dressi ng ofskin tears. Silon-TSR may be left on the wound for 7 to 10 days. The product is transparen t, there by allowi ng wound visualization without removal or dressing changes, and nonadherent.
Circle 143 on Reader Service Card

Nasal Irrigation System
The Sinuf' leanse" system is a convenie nt, effecti ve and eco nomical device for nasa l irrigat ion tha t can help your patient s with comp laints related to dry winter air. Nasal irriga tion is an effec tive way to moisten nasal passage s, as well as rinse dirt, dust and thickened mucus. The SinuCleanse system co mes co mplete with eve rything patient s need to begi n irriga ting their way to better sinonasa l health , including an unbreakable and dishwasher-safe "pot," premixed ingred ients for a buffered saline solution and detailed instructions.
Circle 142 on Reader Service Card BFW' s new Maxenon 180 Power P L US provides bright an d powerful xenon illumination without burning up your budget. It is designed to provi de xenon intens ity without the cos t involved with many of the systems on today' s market.
The Maxenon 180 PowerPLU S is exce llent for headlights and instrume ntation. Approved to UL 260 I and CE standar ds, it accepts BFW, ACMI , Wolf, Stor z and . Olympus cables. Available in worldwide voltage, it also offers a hot-start feature .
Circle 141 on Reader Service Card .
Shortened Regimen for Acute Otitis Media
Pharm acia & Upjohn announce s it has recei ved approval from the Food and Dr ug Admini stration to market Vantin" Ora l Suspension (cef po d ox ime proxetil) as the first and only 5-day ora l cep halosporin antibio tic for chi ldren suffering from mild to moderate acute otitis media. Under the new dai ly dosi ng regimen for Vantin, doctors can now presc ribe 5 mg/kg of the ora l suspension twice a day for 5 days, for children aged 2 mo nths through 12 years . The former dos ing regimen for this condition was 5 mg/kg twice a day for 10 days.
Vantin, which has been marketed in the United States since 1992, demonstrates clinical efficacy against key bacterial pathogens.
Additiona lly, the FDA clea red Vantin in both oral suspension and tablet for mulatio n for the treatment of mild to modera te acute maxillary sinusitis. Th is indication req uires 200 mg tablets twice a day for 10 days, for adults and adolescents ( 13 years and older), and 5 mg/kg ora l suspension twice a day for 10 days , for childre n aged 2 months to 12 years.
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